![Philogen Spa](/common/images/company/BIT_PHIL.png)
Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...
Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...
Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...
Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 20.8 | 21 | 20.4 | 6085 | 20.82955927 | DE |
4 | 0.6 | 2.9702970297 | 20.2 | 21 | 19.8 | 6227 | 20.4132426 | DE |
12 | 2.45 | 13.3514986376 | 18.35 | 21.6 | 17.6 | 10195 | 19.93863373 | DE |
26 | 2.2 | 11.8279569892 | 18.6 | 21.6 | 16.3 | 10749 | 18.63587332 | DE |
52 | 4.95 | 31.2302839117 | 15.85 | 21.6 | 15.5 | 11968 | 18.12189509 | DE |
156 | 7.8 | 60 | 13 | 21.6 | 13 | 10222 | 15.93208412 | DE |
260 | 3.8 | 22.3529411765 | 17 | 21.6 | 12.6 | 12845 | 15.75921511 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.